Phospholipase D activation in PDGF-stimulated vascular smooth muscle cells.
Randall
R W
RW
Wellcome Research Laboratories, Beckenham, Kent.
Spacey
G D
GD
Bonser
R W
RW
D000470:Alkaloids / Q000494:pharmacology; D000818:Animals; D000077214:Becaplermin; D002227:Carbazoles / Q000494:pharmacology; D002460:Cell Line; D004789:Enzyme Activation; D026121:Indole Alkaloids; D007700:Kinetics; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000201:enzymology*; D010739:Phospholipase D / Q000378:metabolism*; D010766:Phosphorylation; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology*; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000378:metabolism; D020574:Proto-Oncogene Proteins c-sis; D051381:Rats; D017479:Receptors, Platelet-Derived Growth Factor / Q000187:drug effects / Q000378:metabolism*; D011994:Recombinant Proteins / Q000494:pharmacology; D015398:Signal Transduction; D019311:Staurosporine
D000470:Alkaloids; D002227:Carbazoles; D026121:Indole Alkaloids; D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D011994:Recombinant Proteins; D000077214:Becaplermin; C049985:staurosporine aglycone; D017479:Receptors, Platelet-Derived Growth Factor; D011493:Protein Kinase C; D010739:Phospholipase D; D019311:Staurosporine